ADJUVANS FÜR VAKZINEN

Patent europeic · EP1265633 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1265633
Numer da la dumonda
EP01931522
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-03-2001
Publitgà
18-12-2002
Concedì
12-12-2012
Stritgà
31-03-2014
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/39 (2006.01)
A61K 39/295 (2006.01)
A61K 39/116 (2006.01)
A61P 37/04 (2006.01)
A61P 31/00 (2006.01)
Prioritad
DE 10012370 14.03.2000
Dumonda PCT
PCT/EP2001/002866 14.03.2001
Publicaziun PCT
WO2001/068129 20.09.2001
Lingua da l’annunzia
tudestg
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-10-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.10.2014

  2. 29-12-2012

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 29.12.2012

  3. 12-12-2012

    Concedì

    Published in Swissreg on 12.12.2012

Partidas

Possessur

Novartis Vaccines and Diagnostics GmbH

Emil-von-Behring-Strasse 76, 35041 Marburg, DE

Represchentant

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventur

BROKER, Michael

35041 Marburg, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.